Microvesicles as potential ovarian cancer biomarkers

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Giusti, Ilaria ^a   D'Ascenzo, Sandra ^a   Dolo, Vincenza ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; MICRORNA; MEMBRANE PROTEIN; MUC16 PROTEIN, HUMAN; TUMOR MARKER;

ADVANCED CANCER; CANCER CELL; CANCER DIAGNOSIS; CANCER SURVIVAL; CELL VACUOLE; DISEASE SEVERITY; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; MICROVESICLE; OVARY CANCER; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; UPREGULATION; ANIMAL; BLOOD; MEMBRANE MICROPARTICLE; METABOLISM; MORTALITY; OVARY TUMOR; OVARIAN NEOPLASMS;

ANIMALS; CA-125 ANTIGEN; CELL-DERIVED MICROPARTICLES; FEMALE; HUMANS; MEMBRANE PROTEINS; OVARIAN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84874592320     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/703048     Document Type: Review

References (111)

1. Rak J., Microparticles in cancer. Seminars in Thrombosis and Hemostasis 2010 36 8 888 906 2-s2.0-78149352576 10.1055/s-0030-1267043
2. Schifferli J. A., Microvesicles are messengers. Seminars in Immunopathology 2011 33 5 393 394
3. Shai E., Varon D., Development, cell differentiation, angiogenesis-microparticles and their roles in angiogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 1 10 14 2-s2.0-78650882636 10.1161/ATVBAHA.109.200980
4. Enjeti A. K., Lincz L. F., Seldon M., Microparticles in health and disease. Seminars in Thrombosis and Hemostasis 2008 34 7 683 691 2-s2.0-58149093081 10.1055/s-0028-1104547
5. Mathivanan S., Ji H., Simpson R. J., Exosomes: extracellular organelles important in intercellular communication. Journal of Proteomics 2010 73 10 1907 1920 2-s2.0-77956404647 10.1016/j.jprot.2010.06.006
6. Gyorgy B., Modos K., Pallinger E., Detection and isolation of cell-derived microparticles are compromised by protein complexes due to shared biophysical parameters. Blood 2011 117 4 e39 e48
7. Kerr J. F., Wyllie A. H., Currie A. R., Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. British Journal of Cancer 1972 26 4 239 257 2-s2.0-0015383455
8. Trams E. G., Lauter C. J., Salem N., Heine U., Exfoliation of membrane ecto-enzymes in the form of micro-vesicles. Biochimica et Biophysica Acta 1981 645 1 63 70 2-s2.0-0019874126
9. Théry C., Amigorena S., Raposo G., Clayton A., Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Current Protocols in Cell Biology 2006 3 3.22 2-s2.0-43249109372
10. Théry C., Ostrowski M., Segura E., Membrane vesicles as conveyors of immune responses. Nature Reviews 2009 9 8 581 593
11. Al-Nedawi K., Meehan B., Micallef J., Lhotak V., May L., Guha A., Rak J., Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nature Cell Biology 2008 10 5 619 624 2-s2.0-43049139913 10.1038/ncb1725 (Pubitemid 351627382)
12. Valadi H., Ekström K., Bossios A., Sjöstrand M., Lee J. J., Lötvall J. O., Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature Cell Biology 2007 9 6 654 659 2-s2.0-34249302620 10.1038/ncb1596 (Pubitemid 47214727)
13. Chargaff E., West R., The biological significance of the thromboplastic protein of blood. Journal of Biological Chemistry 1946 166 1 189 197
14. Hugel B., Zobairi F., Freyssinet J. M., Measuring circulating cell-derived microparticles. Journal of Thrombosis and Haemostasis 2004 2 1846 1847
15. Dolo V., Ginestra A., Ghersi G., Nagase H., Vittorelli M. L., Human breast carcinoma cells cultured in the presence of serum shed membrane vesicles rich in gelatinolytic activities. Journal of Submicroscopic Cytology and Pathology 1994 26 2 173 180 2-s2.0-0028409113 (Pubitemid 2080205)
16. Antonyak M. A., Li B., Boroughs L. K., Johnson J. L., Druso J. E., Bryant K. L., Holowka D. A., Cerione R. A., Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells. Proceedings of the National Academy of Sciences of the United States of America 2011 108 12 4852 4857 2-s2.0-79953229234 10.1073/pnas. 1017667108
17. Hugel B., Martínez M. C., Kunzelmann C., Freyssinet J. M., Membrane microparticles: two sides of the coin. Physiology 2005 20 22 27 (Pubitemid 40363367)
18. D'Souza-Schorey C., Clancy J. W., Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers. Genes & Development 2012 26 12 1287 1299
19. Skog J., Würdinger T., van Rijn S., Meijer D. H., Gainche L., Curry W. T., Carter B. S., Krichevsky A. M., Breakefield X. O., Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nature Cell Biology 2008 10 12 1470 1476 2-s2.0-57049103401 10.1038/ncb1800
20. Mause S. F., Weber C., Microparticles: protagonists of a novel communication network for intercellular information exchange. Circulation Research 2010 107 9 1047 1057 2-s2.0-78349285166 10.1161/CIRCRESAHA.110.226456
21. Taraboletti G., D'Ascenzo S., Borsotti P., Giavazzi R., Pavan A., Dolo V., Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells. American Journal of Pathology 2002 160 2 673 680 2-s2.0-0036172425 (Pubitemid 34160345)
22. Dolo V., D'Ascenzo S., Giusti I., Millimaggi D., Taraboletti G., Pavan A., Shedding of membrane vesicles by tumor and endothelial cells. Italian Journal of Anatomy and Embryology 2005 110 2 127 133 2-s2.0-22244468340 (Pubitemid 40993967)
23. Ginestra A., la Placa M. D., Saladino F., Cassarà D., Nagase H., Vittorelli M. L., The amount and proteolytic content of vesicles shed by human cancer cell lines correlates with their in vitro invasiveness. Anticancer Research 1998 18 5 3433 3437 2-s2.0-0031760355 (Pubitemid 28546471)
24. Inal J. M., Ansa-Addo E. A., Stratton D., Microvesicles in health and disease. Archivum Immunologiae et Therapiae Experimentalis 2012 60 2 107 121
25. Angelucci A., D'Ascenzo S., Festuccia C., Gravina G. L., Bologna M., Dolo V., Pavan A., Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines. Clinical and Experimental Metastasis 2000 18 2 163 170 2-s2.0-0035118749 10.1023/A:1006778000173 (Pubitemid 32165250)
26. Graves L. E., Ariztia E. V., Navari J. R., Matzel H. J., Stack M. S., Fishman D. A., Proinvasive properties of ovarian cancer ascites-derived membrane vesicles. Cancer Research 2004 64 19 7045 7049 2-s2.0-4944223380 10.1158/0008-5472.CAN-04-1800 (Pubitemid 39331015)
27. van Doormaal F. F., Kleinjan A., Di Nisio M., Büller H. R., Nieuwland R., Cell-derived microvesicles and cancer. Netherlands Journal of Medicine 2009 67 7 266 273 2-s2.0-69749115964
28. Abid Hussein M. N., Böing A. N., Sturk A., Hau C. M., Nieuwland R., Inhibition of microparticle release triggers endothelial cell apoptosis and detachment. Thrombosis and Haemostasis 2007 98 5 1096 1107 2-s2.0-36148963746 10.1160/TH05-04-0231 (Pubitemid 350107696)
29. Shedden K., Xie X. T., Chandaroy P., Chang Y. T., Rosania G. R., Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles. Cancer Research 2003 63 15 4331 4337 2-s2.0-0043092308 (Pubitemid 36950999)
30. Huber V., Fais S., Iero M., Lugini L., Canese P., Squarcina P., Zaccheddu A., Colone M., Arancia G., Gentile M., Seregni E., Valenti R., Ballabio G., Belli F., Leo E., Parmiani G., Rivoltini L., Human colorectal cancer cells induce T-cell death through release of proapoptotic microvesicles: role in immune escape. Gastroenterology 2005 128 7 1796 1804 2-s2.0-20444453596 10.1053/j.gastro.2005.03.045 (Pubitemid 40824690)
31. Jeong W. K., Wieckowski E., Taylor D. D., Reichert T. E., Watkins S., Whiteside T. L., Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes. Clinical Cancer Research 2005 11 3 1010 1020 2-s2.0-12944329896 (Pubitemid 40175748)
32. Valenti R., Huber V., Iero M., Filipazzi P., Parmiani G., Rivoltini L., Tumor-released microvesicles as vehicles of immunosuppression. Cancer Research 2007 67 7 2912 2915 2-s2.0-34248216649 10.1158/0008-5472.CAN-07-0520 (Pubitemid 46724823)
33. Whitlow M. B., Klein L. M., Response of SCC-12F, a human squamous cell carcinoma cell line, to complement attack. Journal of Investigative Dermatology 1997 109 1 39 45 2-s2.0-0030750578 (Pubitemid 27305647)
34. Carmeliet P., Angiogenesis in life, disease and medicine. Nature 2005 438 7070 932 936 2-s2.0-30744479430 10.1038/nature04478 (Pubitemid 43093958)
35. Tang D. G., Conti C. J., Endothelial cell development, vasculogenesis, angiogenesis, and tumor neovascularization: an update. Seminars in Thrombosis and Hemostasis 2004 30 1 109 117 2-s2.0-1842555340 10.1055/s-2004-822975 (Pubitemid 38457305)
36. Al-Nedawi K., Meehan B., Kerbel R. S., Allison A. C., Rak A., Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR. Proceedings of the National Academy of Sciences of the United States of America 2009 106 10 3794 3799 2-s2.0-62649095692 10.1073/pnas.0804543106
37. Millimaggi D., Mari M., D'Ascenzo S., Carosa E., Jannini E. A., Zucker S., Carta G., Pavan A., Dolo V., Tumor vesicle-associated CD147 modulates the angiogenic capability of endothelial cells. Neoplasia 2007 9 4 349 357 2-s2.0-34247197062 10.1593/neo.07133 (Pubitemid 46608302)
38. Taraboletti G., D'Ascenzo S., Giusti I., Marchetti D., Borsotti P., Millimaggi D., Giavazzi R., Pavan A., Dolo V., Bioavailability of VEGF in tumor-shed vesicles depends on vesicle burst induced by acidic pH 1. Neoplasia 2006 8 2 96 103 2-s2.0-33646420333 10.1593/neo.05583
39. Giusti I., D'Ascenzo S., Millimaggi D., Taraboletti G., Carta G., Franceschini N., Pavan A., Dolo V., Cathepsin B mediates the pH-dependent proinvasive activity of tumor-shed microvesicles. Neoplasia 2008 10 5 481 488 2-s2.0-43249119195 10.1593/neo.08178 (Pubitemid 351657390)
40. Lee T. H., D'Asti E., Magnus N., Al-Nedawi K., Meehan B., Rak J., Microvesicles as mediators of intercellular communication in cancer-the emerging science of cellular ''debris''. Seminars in Immunopathology 2011 33 5 455 467
41. Camussi G., Deregibus M. C., Bruno S., Exosoome/microvesicle-mediated epigenetic reprogramming of cells. American Journal of Cancer Research 2011 1 1 98 110
42. Kim C. W., Lee H. M., Lee T. H., Extracellular membrane vesicles from tumor cells promote angiogenesis via sphingomyelin. Cancer Research 2002 62 6312 6317 (Pubitemid 35244486)
43. Jayachandran M., Miller V. M., Heit J. A., Owen W. G., Methodology for isolation, identification and characterization of microvesicles in peripheral blood. Journal of Immunological Methods 2012 375 1-2 207 214
44. Toth B., Liebhardt S., Steinig K., Ditsch N., Rank A., Bauerfeind I., Spannagl M., Friese K., Reininger A. J., Platelet-derived microparticles and coagulation activation in breast cancer patients. Thrombosis and Haemostasis 2008 100 4 663 669 2-s2.0-54949090343 10.1160/TH07-10-0602
45. Zwicker J. I., Liebman H. A., Neuberg D., Lacroix R., Bauer K. A., Furie B. C., Furie B., Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clinical Cancer Research 2009 15 22 6830 6840 2-s2.0-72549102588 10.1158/1078-0432.CCR-09-0371
46. VanWijk M. J., VanBavel E., Sturk A., Nieuwland R., Microparticles in cardiovascular diseases. Cardiovascular Research 2003 59 2 277 287 2-s2.0-0142122248 10.1016/S0008-6363(03)00367-5 (Pubitemid 37272022)
47. Berckmans R. J., Nieuwland R., Böing A. N., Romijn F. P., Hack C. E., Sturk A., Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thrombosis and Haemostasis 2001 85 4 639 646 2-s2.0-0035070809 (Pubitemid 32293699)
48. Joop K., Berckmans R. J., Nieuwland R., Berkhout J., Romijn F. P. H. T. M., Hack C. E., Sturk A., Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms. Thrombosis and Haemostasis 2001 85 5 810 820 2-s2.0-0035002186 (Pubitemid 32421813)
49. Gross P. L., Furie B. C., Merrill-Skoloff G., Chou J., Furie B., Leukocyte-versus microparticle-mediated tissue factor transfer during arteriolar thrombus development. Journal of Leukocyte Biology 2005 78 6 1318 1326 2-s2.0-28844471517 10.1189/jlb.0405193 (Pubitemid 41779238)
50. Thomas G. M., Panicot-Dubois L., Lacroix R., Cancer cell-derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo. Journal of Experimental Medicine 2009 206 9 1913 1927
51. Yuana Y., Oosterkamp T. H., Bahatyrova S., Ashcroft B., Garcia Rodriguez P., Bertina R. M., Osanto S., Atomic force microscopy: a novel approach to the detection of nanosized blood microparticles. Journal of Thrombosis and Haemostasis 2010 8 2 315 323 2-s2.0-74749093227 10.1111/j.1538-7836.2009.03654.x
52. Yuana Y., Bertina R. M., Osanto S., Pre-analytical and analytical issues in the analysis of blood microparticles. Journal of Thrombosis and Haemostasis 2011 105 3 396 408
53. Michelsen A. E., Wergeland R., Stokke O., Brosstad F., Development of a time-resolved immunofluorometric assay for quantifying platelet-derived microparticles in human plasma. Thrombosis Research 2006 117 6 705 711 2-s2.0-33646063165 10.1016/j.thromres.2005.05.024
54. Jy W., Horstman L. L., Jimenez J. J., Measuring circulating cell-derived microparticles. Journal of Thrombosis and Haemostasis 2004 2 10 1842 1851 (Pubitemid 40197488)
55. Lacroix R., Robert S., Poncelet P., Kasthuri R. S., Key N. S., Dignat-George F., Standardization of platelet-derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC collaborative workshop. Journal of Thrombosis and Haemostasis 2010 8 11 2571 2574 2-s2.0-78149252105 10.1111/j.1538-7836.2010. 04047.x
56. Robert S., Poncelet P., Lacroix R., Arnaud L., Giraudo L., Hauchard A., Sampol J., Dignat-George F., Standardization of platelet-derived microparticle counting using calibrated beads and a Cytomics FC500 routine flow cytometer: a first step towards multicenter studies? Journal of Thrombosis and Haemostasis 2009 7 1 190 197 2-s2.0-57749190349 10.1111/j.1538-7836.2008.03200.x
57. Connor D. E., Exner T., Ma D. D. F., Joseph J. E., The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib. Thrombosis and Haemostasis 2010 103 5 1044 1052 2-s2.0-77952074366 10.1160/TH09-09-0644
58. Flaumenhaft R., Dilks J. R., Richardson J., Alden E., Sunita R. P. H., Battinelli E., Klement G. L., Martha S. V., Italiano J. E., Megakaryocyte- derived microparticles: direct visualization and distinction from platelet-derived microparticles. Blood 2009 113 5 1112 1121 2-s2.0-60849089339 10.1182/blood-2008-06-163832
59. Cerri C., Chimenti D., Conti I., Neri T., Paggiaro P., Celi A., Monocyte/macrophage-derived microparticles up-regulate inflammatory mediator synthesis by human airway epithelial cells. Journal of Immunology 2006 177 3 1975 1980 2-s2.0-33746214732 (Pubitemid 44092538)
60. Joos T. O., Bachmann J., The promise of biomarkers: research and applications. Drug Discovery Today 2005 10 9 615 616 2-s2.0-18944402613 10.1016/S1359-6446(05)03448-3 (Pubitemid 40704768)
61. Nozaki T., Sugiyama S., Sugamura K., Ohba K., Matsuzawa Y., Konishi M., Matsubara J., Akiyama E., Sumida H., Matsui K., Jinnouchi H., Ogawa H., Prognostic value of endothelial microparticles in patients with heart failure. European Journal of Heart Failure 2010 12 11 1223 1228 2-s2.0-77958600613 10.1093/eurjhf/hfq145
62. Chironi G., Simon A., Hugel B., Pino M. D., Gariepy J., Freyssinet J. M., Tedgui A., Circulating leukocyte-derived microparticles predict subclinical atherosclerosis burden in asymptomatic subjects. Arteriosclerosis, Thrombosis, and Vascular Biology 2006 26 12 2775 2780 2-s2.0-33751179456 10.1161/01.ATV.0000249639.36915.04
63. Preston R. A., Jy W., Jimenez J. J., Mauro L. M., Horstman L. L., Valle M., Aime G., Ahn Y. S., Effects of severe hypertension on endothelial and platelet microparticles. Hypertension 2003 41 2 211 217 2-s2.0-0037315391 10.1161/01.HYP.0000049760.15764.2D (Pubitemid 36204891)
64. Minagar A., Jy W., Jimenez J. J., Sheremata W. A., Mauro L. M., Mao W. W., Horstman L. L., Ahn Y. S., Elevated plasma endothelial microparticles in multiple sclerosis. Neurology 2001 56 10 1319 1324 2-s2.0-0035933189 (Pubitemid 32455291)
65. Sabatier F., Darmon P., Hugel B., Combes V., Sanmarco M., Velut J. G., Arnoux D., Charpiot P., Freyssinet J. M., Oliver C., Sampol J., Dignat-George F., Type 1 and type 2 diabetic patients display different patterns of cellular microparticles. Diabetes 2002 51 9 2840 2845 2-s2.0-0036724722 (Pubitemid 34970939)
66. Brogan P. A., Dillon M. J., Endothelial microparticles and the diagnosis of the vasculitides. Internal Medicine 2004 43 12 1115 1119 2-s2.0-11344290360 10.2169/internalmedicine.43.1115 (Pubitemid 40074145)
67. Knijff-Dutmer E. A. J., Koerts J., Nieuwland R., Kalsbeek-Batenburg E. M., van de Laar M. A., Elevated levels of platelet microparticles are associated with disease activity in rheumatoid arthritis. Arthritis and Rheumatism 2002 46 6 1498 1503 2-s2.0-0036269448 10.1002/art.10312 (Pubitemid 34620195)
68. Simak J., Holada K., Risitano A. M., Zivny J. H., Young N. S., Vostal J. G., Elevated circulating endothelial membrane microparticles in paroxysmal nocturnal haemoglobinuria. British Journal of Haematology 2004 125 6 804 813 2-s2.0-3042693914 10.1111/j.1365-2141.2004.04974.x (Pubitemid 38813608)
69. Jung K. H., Chu K., Lee S. T., Circulating endothelial microparticles as a marker of cerebrovascular disease. Annals of Neurology 2009 66 2 191 199
70. Colombo E., Borgiani B., Verderio C., Furlan R., Microvesicles: novel biomarkers for neurological disorders. Frontiers in Physiology 2012 3, article 63
71. Tesselaar M. E. T., Romijn F. P. H. T. M., van der Linden I. K., Prins F. A., Bertina R. M., Osanto S., Microparticle-associated tissue factor activity: a link between cancer and thrombosis? Journal of Thrombosis and Haemostasis 2007 5 3 520 527 2-s2.0-34247606502 10.1111/j.1538-7836.2007.02369.x (Pubitemid 46680685)
72. Kim H. K., Song K. S., Park Y. S., Kang Y. H., Lee Y. J., Lee K. R., Kim H. K., Ryu K. W., Bae J. M., Kim S., Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. European Journal of Cancer 2003 39 2 184 191 2-s2.0-0037220119 10.1016/S0959-8049(02)00596-8 (Pubitemid 36057068)
73. Smalley D. M., Sheman N. E., Nelson K., Theodorescu D., Isolation and identification of potential urinary microparticle biomarkers of bladder cancer. Journal of Proteome Research 2008 7 5 2088 2096 2-s2.0-52049112613 10.1021/pr700775x
74. Huttner H. B., Janich P., Köhrmann M., Jászai J., Siebzehnrubl F., Blümcke I., Suttorp M., Gahr M., Kuhnt D., Nimsky C., Krex D., Schackert G., Löwenbrück K., Reichmann H., Jüttler E., Hacke W., Schellinger P. D., Schwab S., Wilsch-Bräuninger M., Marzesco A. M., Corbeil D., The stem cell marker prominin-1/CD133 on membrane particles in human cerebrospinal fluid offers novel approaches for studying central nervous system disease. Stem Cells 2008 26 3 698 705 2-s2.0-43049120703 10.1634/stemcells. 2007-0639
75. Helley D., Banu E., Bouziane A., Banu A., Scotte F., Fischer A. M., Oudard S., Platelet microparticles: a potential predictive factor of survival in hormone-refractory prostate cancer patients treated with docetaxel-based chemotherapy. European Urology 2009 56 3 479 485 2-s2.0-67651015630 10.1016/j.eururo.2008.06.038
76. Arteaga C. L., Sliwkowski M. X., Osborne C. K., Perez E. A., Puglisi F., Gianni L., Treatment of HER2-positive breast cancer: current status and future perspectives. Nature Reviews 2011 9 1 16 32
77. Chan J. K., Cheung M. K., Husain A., Patterns and progress in ovarian cancer over 14 years. Obstetrics & Gynecology 2006 108 3, part 1 521 528 (Pubitemid 44337091)
78. Torres A., Torres K., Maciejewski R., Harvey W. H., microRNAs and their role in gynecological tumors. Medicinal Research Reviews 2011 31 6 895 923
79. Lutz A. M., Willmann J. K., Drescher C. W., Ray P., Cochran F. V., Urban N., Gambhir S. S., Early diagnosis of ovarian carcinoma: is a solution in sight? Radiology 2011 259 2 329 345 2-s2.0-79955010368 10.1148/radiol.11090563
80. Heintz A. P., Odicino F., Maisonneuve P., Carcinoma of the ovary. FIGO 26th annual report on the results of treatment in gynecological cancer. International Journal of Gynaecology and Obstetrics 2006 95 supplement 1 S161 S192
81. Kobayashi E., Ueda Y., Matsuzaki S., Biomarkers for screening, diagnosis and monitoring of ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention 2012 21 11 1902 1912 10.1158/1055-9965.EPI-12-0646
82. Goff B. A., Mandel L. S., Drescher C. W., Urban N., Gough S., Schurman K. M., Patras J., Mahony B. S., Robyn Andersen M., Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer 2007 109 2 221 227 2-s2.0-33846245932 10.1002/cncr.22371 (Pubitemid 46106236)
83. del Carmen M. G., Educational Book of the American Society of Clinical Oncology 2006 Alexandria, VA, USA American Society of Clinical Oncology
84. Ozols R., Rubin S., Thomas G., Robboy S., Principles and Practice of Gynecologic Oncology 2005 4th Philadelphia, Pa, USA Lippincott Williams & Wilkins
85. Díaz-Padilla I., Razak A. R., Minig L., Bernardini M. Q., María Del Campo J., Prognostic and predictive value of CA-125 in the primary treatment of epithelial ovarian cancer: potentials and pitfalls. Clinical & Translational Oncology 2012 14 1 15 20
86. Sevinc A., Adli M., Kalender M. E., Camci C., Benign causes of increased serum CA-125 concentration. Lancet Oncology 2007 8 12 1054 1055 2-s2.0-36549042456 10.1016/S1470-2045(07)70357-1 (Pubitemid 350182965)
87. Anderson G. L., Ovarian cancer biomarker screening: still too early to tell. Women's Health 2010 6 4 487 490 2-s2.0-77954417004 10.2217/whe.10.33
88. Chendrimada T. P., Finn K. J., Ji X., Baillat D., Gregory R. I., Liebhaber S. A., Pasquinelli A. E., Shiekhattar R., MicroRNA silencing through RISC recruitment of eIF6. Nature 2007 447 7146 823 828 2-s2.0-34249282938 10.1038/nature05841 (Pubitemid 46920131)
89. He L., Hannon G. J., microRNAs: small RNAs with a big role in gene regulation. Nature Reviews Genetics 2004 5 7 522 531 2-s2.0-3042767202 10.1038/nrg1379 (Pubitemid 38868508)
90. Chen X., Ba Y., Ma L., Cai X., Yin Y., Wang K., Guo J., Zhang Y., Chen J., Guo X., Li Q., Li X., Wang W., Zhang Y., Wang J., Jiang X., Xiang Y., Xu C., Zheng P., Zhang J., Li R., Zhang H., Shang X., Gong T., Ning G., Wang J., Zen K., Zhang J., Zhang C. Y., Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Research 2008 18 10 997 1006 2-s2.0-53349177819 10.1038/cr.2008.282
91. Corney D. C., Nikitin A. Y., MicroRNA and ovarian cancer. Histology and Histopathology 2008 23 7-9 1161 1169 2-s2.0-48049087395
92. Rosenfeld N., Aharonov R., Meiri E., microRNAs accurately identify cancer tissue origin. Nature Biotechnology 2008 26 4 462 469 (Pubitemid 351501813)
93. Iorio M. V., Visone R., di Leva G., MicroRNA signatures in human ovarian cancer. Ovarian Research 2007 67 18 8699 8707 (Pubitemid 47437445)
94. Bagnoli M., de Cecco L., Granata A., Identification of a chrXq27.3 microRNA cluster associated with early relapse in advanced stage ovarian cancer patients. Oncotarget 2011 2 12 1265 1278
95. Wyman S. K., Parkin R. K., Mitchell P. S., Fritz B. R., O'Briant K., Godwin A. K., Urban N., Drescher C. W., Knudsen B. S., Tewari M., Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries. PLoS ONE 2009 4 4, article e5311 2-s2.0-65349147075 10.1371/journal.pone.0005311
96. Yanaihara N., Caplen N., Bowman E., Seike M., Kumamoto K., Yi M., Stephens R. M., Okamoto A., Yokota J., Tanaka T., Calin G. A., Liu C. G., Croce C. M., Harris C. C., Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006 9 3 189 198 2-s2.0-33644819964 10.1016/j.ccr.2006.01.025 (Pubitemid 43357945)
97. Bloomston M., Frankel W. L., Petrocca F., Volinia S., Alder H., Hagan J. P., Liu C. G., Bhatt D., Taccioli C., Croce C. M., microRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. Journal of the American Medical Association 2007 297 17 1901 1908 2-s2.0-34247862190 10.1001/jama.297.17.1901 (Pubitemid 46707844)
98. Iorio M. V., Ferracin M., Liu C. G., microRNA gene expression deregulation in human breast cancer. Cancer Research 2005 65 7065 7070 (Pubitemid 41161233)
99. Schetter A. J., Leung S. Y., Sohn J. J., Zanetti K. A., Bowman E. D., Yanaihara N., Yuen S. T., Chan T. L., Kwong D. L. W., Au G. K. H., Liu C. G., Calin G. A., Croce C. M., Harris C. C., microRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. Journal of the American Medical Association 2008 299 4 425 436 2-s2.0-38749089854 10.1001/jama.299.4.425 (Pubitemid 351185951)
100. Calin G. A., Ferracin M., Cimmino A., A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. The New England Journal of Medicine 2005 353 1793 1801 (Pubitemid 41549891)
101. Yang N., Kaur S., Volinia S., Greshock J., Lassus H., Hasegawa K., Liang S., Leminen A., Deng S., Smith L., Johnstone C. N., Chen X. M., Liu C. G., Huang Q., Katsaros D., Calin G. A., Weber B. L., Bützow R., Croce C. M., Coukos G., Zhang L., microRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. Cancer Research 2008 68 24 10307 10314 2-s2.0-57749105325 10.1158/0008-5472.CAN-08-1954
102. Mikaelian I., Scicchitano M., Mendes O., Thomas R. A., Leroy B. E., Frontiers in preclinical safety biomarkers: microRNAs and messenger RNAs. Toxicologic Pathology 2013 41 1 18 31 10.1177/0192623312448939
103. Kuhlmann J. D., Rasch J., Wimberger P., Kasimir-Bauer S., microRNA and the pathogenesis of ovarian cancer-a new horizon for molecular diagnostics and treatment? Clinical Chemistry and Laboratory Medicine 2012 50 4 601 615
104. Taylor D. D., Gercel-Taylor C., microRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecologic Oncology 2008 110 1 13 21 2-s2.0-45449093192 10.1016/j.ygyno.2008.04.033 (Pubitemid 351853251)
105. Resnick K. E., Alder H., Hagan J. P., Richardson D. L., Croce C. M., Cohn D. E., The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecologic Oncology 2009 112 1 55 59 2-s2.0-57649091633 10.1016/j.ygyno.2008.08.036
106. Ginestra A., Miceli D., Dolo V., Romano F. M., Vittorelli M. L., Membrane vesicles in ovarian cancer fluids: a new potential marker. Anticancer Research 1999 19 4 3439 3445 2-s2.0-0033458876 (Pubitemid 30000200)
107. Dahiya N., Sherman-Baust C. A., Wang T. L., Davidson B., Shih L. M., Zhang Y., Wood W., Becker K. G., Morin P. J., microRNA expression and identification of putative miRNA targets in ovarian cancer. PLoS ONE 2008 3 6, article e2436 2-s2.0-49149086082 10.1371/journal.pone.0002436
108. Zhang L., Volinia S., Bonome T., Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Proceedings of the National Academy of Sciences of the United States of America 2008 105 7004 7009 (Pubitemid 351754520)
109. Lee C. H., Subramanian S., Beck A. H., Espinosa I., Senz J., Zhu S. X., Huntsman D., van de Rijn M., Gilks C. B., microRNA profiling of BRCA1/2 mutation-carrying and non-mutation-carrying high-grade serous carcinomas of ovary. PLoS ONE 2009 4 10, article e7314 2-s2.0-70350128013 10.1371/journal. pone.0007314
110. Nam E. J., Yoon H., Kim S. W., microRNA expression profiles in serous ovarian carcinoma. Clinical Cancer Research 2008 14 2690 2695
111. Sorrentino A., Liu C. G., Addario A., Peschle C., Scambia G., Ferlini C., Role of microRNAs in drug-resistant ovarian cancer cells. Gynecologic Oncology 2008 111 3 478 486 2-s2.0-56449108015 10.1016/j.ygyno.2008.08.017